摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Dodecenol | 58877-59-1

中文名称
——
中文别名
——
英文名称
Dodecenol
英文别名
(E)-dodec-1-en-1-ol
Dodecenol化学式
CAS
58877-59-1
化学式
C12H24O
mdl
——
分子量
184.32
InChiKey
CQKHFONAFZDDKV-VAWYXSNFSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.5
  • 重原子数:
    13
  • 可旋转键数:
    9
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.83
  • 拓扑面积:
    20.2
  • 氢给体数:
    1
  • 氢受体数:
    1

文献信息

  • [EN] USE OF SOLUBLE METAL SALTS IN METATHESIS REACTIONS<br/>[FR] UTILISATION DE SELS MÉTALLIQUES SOLUBLES DANS DES RÉACTIONS DE MÉTATHÈSE
    申请人:MATERIA INC
    公开号:WO2014152309A1
    公开(公告)日:2014-09-25
    The present invention describes the use of soluble metal salts to reduce impurities and metathesis catalysts poisons from olefinic feedstocks to improve olefin metathesis efficiency. The soluble metal salts were added to the olefinic feedstocks to prevent peroxides and catalyst poisons from inhibiting the metathesis catalyst. The soluble metal salts remain in the olefinic feedstocks and are used without further purification in the olefin metathesis reactions. The key to this invention is the soluble metal salt compounds do not inhibit the olefin metathesis catalysts but unexpectedly increase olefin metathesis catalyst efficiency while prior art heterogeneous metal complexes sequester the olefin metathesis catalyst, preventing olefin metathesis.
    本发明描述了利用可溶性金属盐来减少烯烃原料中的杂质和醚交换催化剂毒物,以提高烯烃醚交换效率。可溶性金属盐被添加到烯烃原料中,以防止过氧化物和催化剂毒物抑制醚交换催化剂。这些可溶性金属盐留在烯烃原料中,在烯烃醚交换反应中无需进一步纯化即可使用。这项发明的关键在于可溶性金属盐化合物不会抑制烯烃醚交换催化剂,而是意外地提高了烯烃醚交换催化剂的效率,而传统的异质金属络合物会固定烯烃醚交换催化剂,从而阻止烯烃醚交换。
  • Cationic Amino Acid Type Lipid
    申请人:Takeoka Shinji
    公开号:US20090012306A1
    公开(公告)日:2009-01-08
    The present invention provides a novel complex lipid having a cationic functional group derived from an amino acid. Namely, the present invention provides a cationic acid amino acid type lipid represented by the following formula: wherein, R 1 is a hydrocarbon group having a cationic functional group derived from an amino acid, R 2 and R 3 are each independently a chain hydrocarbon group, A 1 and A 2 are each independently a linkage group selected from the group consisting of —COO—, —OCO—, —CONH— and NHCO—, and n is an integer of 2 to 4.
    本发明提供一种新型的复合脂质,其具有源自氨基酸的阳离子功能基团。即,本发明提供一种由以下式表示的阳离子酸氨基酸型脂质:其中,R1是具有源自氨基酸的阳离子功能基团的烃基,R2和R3各自独立地是链烃基,A1和A2各自独立地是从羧基团、酰基团、酰胺基团和酰胺酰基团中选取的连接基团,n是2至4之间的整数。
  • Amide derivatives
    申请人:Muto Susumu
    公开号:US20050215645A1
    公开(公告)日:2005-09-29
    A medicament for enhancing an effect of a cancer therapy based on a mode of action of DNA injury, which comprises as an active ingredient a compound represented by the following general formula (I) or a salt thereof: wherein one of R 1 and R 2 represents hydrogen atom and the other represents the formula —X-A wherein A represents hydrogen atom or an acyl group, X represents oxgen atom or NH; one of R 3 and R 4 represents hydrogen atom and the other represents the following formula: wherein Y represents a sulfonyl group or a carbonyl group, R 5 represents a cyclic group, Z represents a single bond or a C 1 to C 4 alkylene group, R 6 represents hydrogen atom or a C 1 to C 6 alkyl group.
    一种用于增强基于DNA损伤作用的癌症治疗效果的药物,其活性成分为以下一般式(I)或其盐表示的化合物:其中R1和R2中的一个代表氢原子,另一个代表式—X-A,其中A代表氢原子或酰基,X代表氧原子或NH;R3和R4中的一个代表氢原子,另一个代表以下式:其中Y代表磺酰基或羰基,R5代表环状基团,Z代表单键或C1到C4烷基烷基,R6代表氢原子或C1到C6烷基基团。
  • BENZYLOXYPYRIMIDINE DERIVATIVE, AGRICULTURAL/ HORTICULTURAL INSECTICIDE COMPRISING DERIVATIVE AND METHOD FOR USING SAME
    申请人:Kasahara Ryota
    公开号:US20130267564A1
    公开(公告)日:2013-10-10
    A benzyloxypyrimidine derivative represented by the formula (I) wherein R 1 is an alkyl group, a cycloalkyl group, an alkenyl group, an alkynyl group, a haloalkyl group, a haloalkenyl group, a haloalkynyl group, an alkoxyalkyl group and the like; R 2 and R 3 are each a hydrogen atom, an alkyl group and the like; X is an alkyl group, a cycloalkyl group, an alkenyl group, an alkynyl group, a haloalkyl group, a haloalkenyl group, a haloalkynyl group, a trialkylsilyl group and the like; A is a oxygen atom and the like, and m is an integer of 0-5, or a salt thereof, and an agrohorticultural insecticide containing the compound as an active ingredient and a method of use thereof.
    一种苄氧基嘧啶衍生物,由式(I)表示,其中R1是烷基、环烷基、烯基、炔基、卤代烷基、卤代烯基、卤代炔基、烷氧基烷基等;R2和R3分别是氢原子、烷基等;X是烷基、环烷基、烯基、炔基、卤代烷基、卤代烯基、卤代炔基、三烷基硅基等;A是氧原子等,m是0-5的整数,或其盐,以及含有该化合物作为活性成分的农业昆虫杀虫剂和使用方法。
  • CARBOXYLIC ACID-TYPE LIPID, AND LIPID PARTICLE AND LIPID MEMBRANE EACH COMPRISING CARBOXYLIC ACID-TYPE LIPID
    申请人:Toray Industries, Inc.
    公开号:US20210387943A1
    公开(公告)日:2021-12-16
    A carboxylic acid-type lipid can accelerate adhesion or aggregation of platelets even if the carboxylic acid-type lipid does not carry a protein involved in adhesion or aggregation of platelets or a peptide corresponding to an active site of the protein; a lipid particle and a lipid membrane each include the carboxylic acid-type lipid; and a platelet aggregation accelerating agent, a platelet adhesion accelerating agent, a hemostatic agent and a platelet substitute each include the carboxylic acid-type lipid, the lipid particle or the lipid membrane. A carboxylic acid-type lipid is selected from carboxylic acid-type lipids represented by formulas (I) to (VI), a lipid particle includes the carboxylic acid-type lipid, a lipid membrane includes the carboxylic acid-type lipid, and a platelet aggregation accelerating agent, a platelet adhesion accelerating agent, a hemostatic agent and a platelet substitute each include the carboxylic acid-type lipid, the lipid particle or the lipid membrane.
    一种羧酸型脂质即使不携带与血小板粘附或聚集有关的蛋白质或相应的蛋白质活性位点对血小板的粘附或聚集也能加速,脂质颗粒和脂质膜均包括该羧酸型脂质;血小板聚集加速剂、血小板粘附加速剂、止血剂和血小板替代物均包括该羧酸型脂质、脂质颗粒或脂质膜。所述羧酸型脂质选自公式(I)到(VI)所表示的羧酸型脂质,脂质颗粒包括该羧酸型脂质,脂质膜包括该羧酸型脂质,血小板聚集加速剂、血小板粘附加速剂、止血剂和血小板替代物均包括该羧酸型脂质、脂质颗粒或脂质膜。
查看更多